Recent Articles By The Author
Quick takes on fourth-quarter results from these 3 biotech names.
Acquisition deals for biotech companies at the start of 2019 are giving the sector a nice boost; here are other names that could be merger candidates.
Stocks can easily trade down more than 10% instantaneously on a headline 'miss'.
One already is up nicely on its results, while the other two should issue reports of interest in the next few days.
Not much movement in the overall indices since our last update. Solid day for the markets as trade talks seem to be advancing, and hopefully investors will see some sort of deal in the near future. This would remove a major overhang for the markets ...
Stocks are pretty level to where they were an hour into the open. Even contentious press coverage as President Trump announced a national emergency for additional border measures could not derail the rally very much. Markets are now banking on a mem...
Progress in trade talks between the U.S. and China is enough to overcome some disappointing reads on the economy (December retail sales, January industrial production). The Dow is up over 300 points in early going as we try to close out the trading ...